Adapthealth Corp. current report, 22 June 2023

AdaptHealth Corp. 8-K Summary

Business Context and Reporting Period

This Form 8-K Current Report, dated June 22, 2023, discloses significant executive leadership changes at AdaptHealth Corp. (AHCO), a provider of home healthcare services. The filing details the appointment of a new Chief Executive Officer (CEO), the interim leadership arrangement, and the resignation of the General Counsel.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation arrangements and employment terms.

Material Changes and Executive Actions

  • Appointment of CEO: Crispin Teufel was appointed CEO, effective September 1, 2023. He previously served as CEO of Lincare Holdings Inc. since 2017.
  • Interim CEO: Richard Barasch, Chairman of the Board, serves as Interim CEO from July 1, 2023, to August 31, 2023, following the resignation of Stephen P. Griggs (effective June 30, 2023).
  • Resignation of General Counsel: Christopher Joyce resigned as General Counsel, effective July 31, 2023, to pursue other opportunities.

Compensation and Employment Terms

Crispin Teufel (New CEO)

  • Base Salary: $800,000 annually.
  • Target Bonus: 100% of base salary (range 0-200% based on performance).
  • Signing Bonus: $450,000 one-time payment (clawback provisions apply if terminated for cause or resignation without good reason within one year).
  • Equity Grants:
    • $1,000,000 in RSUs vesting on the first anniversary.
    • $1,233,333 in 2023 RSUs (50% time-based vesting over 3 years; 50% performance-based on TSR).
    • $3,700,000 in 2024 RSUs (similar vesting criteria).
  • Severance: Upon termination without cause or for good reason, Teufel is entitled to 24 months of base salary, 2x target bonus, and continued equity vesting.

Richard Barasch (Interim CEO)

  • Interim Salary: $262,500 per month (July 1 - August 31, 2023).
  • Transition Fee: $175,000 per month for transition services (September 1 - December 31, 2023).
  • Equity: $175,000 in RSUs vesting on August 31, 2023.

Outlook and Risks

The filing indicates a strategic leadership transition intended to stabilize and guide the company. No specific financial guidance or forward-looking revenue projections are included in this document. The primary risk disclosed relates to the execution of the leadership transition and the retention of key personnel during the interim period.

Key Facts for Investor Verification

  • Verify the total potential compensation cost for Crispin Teufel, including the $5.933 million in initial equity grants and potential severance liabilities.
  • Confirm the timeline for the transition from Interim CEO Richard Barasch to permanent CEO Crispin Teufel (September 1, 2023).
  • Review the specific performance metrics for the TSR-based equity component of Teufel's compensation.
  • Monitor the impact of the General Counsel resignation on ongoing legal or regulatory matters.